LY231514 Plus Gemcitabine in Treating Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: gemcitabine hydrochloride|DRUG: pemetrexed disodium
Sponsor: Alliance for Clinical Trials in Oncology
Collaborators: National Cancer Institute (NCI)